David Branigan, Intellectual Property Watch; New Research Study Describes DNDi As A “Commons” For Public Health
"Since 2003, Drugs for Neglected Diseases Initiative (DNDi) has worked to
meet the public health needs of neglected populations by filling gaps
in drug development left by the for-profit pharmaceutical industry. A
new research study by the French Development Agency analysed DNDi’s
unique product development partnership (PDP) model, and found that it
“illustrate[s] what can be presented as a ‘commons’ within the area of
public health."
The research study, “DNDi, a Distinctive Illustration of Commons in the Area of Public Health,”
was published earlier this month by the Agence Française de
Développement (AFD), the French public development bank that “works in
many sectors — energy, healthcare, biodiversity, water, digital
technology, professional training, among others — to assist with
transitions towards a safer, more equitable, and more sustainable world:
a world in common,” according to its website."
Showing posts with label Drugs for Neglected Diseases Initiative (DNDi) as a "Commons" for public health. Show all posts
Showing posts with label Drugs for Neglected Diseases Initiative (DNDi) as a "Commons" for public health. Show all posts
Subscribe to:
Comments (Atom)